In October 2022, Minneapolis-based Allina Health and investment firm Flare Capital Partners launched a company called Inbound Health that enables health systems and health plans to offer hospital-at-home and skilled nursing-at-home programs. Now Inbound has announced the closing of a $30 million Series B funding round.
This investment is led by HealthQuest Capital with participation from existing investors Flare Capital Partners and McKesson Ventures.
At the time of its launch, Allina said the new company provides the full stack of capabilities that are required to scale at-home care models including home-based care pathways, virtual care teams, engagement and workflow technology, analytics, supply chain partnerships, operational oversight and payment models. It added that the company offers a flexible partnership structure, enabling customers to leverage their existing assets and capabilities while relying on Inbound Health to fill the gaps required to scale these programs across their service area.
In July 2023, Julia Crist, the company’s chief operating officer, described the company's origins and strategies to Healthcare Innovation. She said one health system had signed the management services agreement, and Inbound would be starting in their market in October, and had signed a letter of intent with another partner. “They're both multi-state health systems who have their own home health assets and a lot of the supply chain components like durable medical equipment and lab, but need the kind of plug-in services that Inbound brings,” she said.
"We are excited to embark on this next phase of growth with the strong backing of our investors, led by HealthQuest Capital," said Dave Kerwar, CEO of Inbound Health, in a statement. "In partnership with leading health systems around the country, we are committed to advancing our clinical, operating, and technology assets to scale high-quality, advanced care in the home and to increase the acuity and diversity of care delivered.”
Inbound said the financing supports its expansion into new markets and the advancement of key growth initiatives, including further development of the company's clinical programs, the next evolution of its proprietary technology and advanced analytics platform, and the continued build-out of customized operating assets focused on supply chain, labor, and logistics.